You can:
Name | Delta-type opioid receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | OPRD1 |
Synonym | D-OR-1 DOR opioid receptor OP1 DOP [ Show all ] |
Disease | Cough Overactive bladder disorder Bladder disease Moderate-to-severe pain Diarrhea-predominant IBS [ Show all ] |
Length | 372 |
Amino acid sequence | MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA |
UniProt | P41143 |
Protein Data Bank | 4rwd, 4rwa, 4n6h |
GPCR-HGmod model | P41143 |
3D structure model | This structure is from PDB ID 4rwd. |
BioLiP | BL0303696,BL0303697, BL0265712, BL0265705,BL0265706,BL0265707,, BL0303699,BL0303701, BL0303698,BL0303700 |
Therapeutic Target Database | T58992 |
ChEMBL | CHEMBL236 |
IUPHAR | 317 |
DrugBank | BE0000420 |
Name | CHEMBL3616878 |
---|---|
Molecular formula | C82H114N22O17S |
IUPAC name | (2S)-2-[[1-[(3R)-2-[(2S)-2-[[2-[[2-[[1-[(2S)-1-[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-carbamimidamidopentanoic acid |
Molecular weight | 1712.01 |
Hydrogen bond acceptor | 22 |
Hydrogen bond donor | 21 |
XlogP | -2.9 |
Synonyms | BDBM50121679 |
Inchi Key | RNRZOTCBHVPTGT-NWFAGNJCSA-N |
Inchi ID | InChI=1S/C82H114N22O17S/c83-54(36-47-26-28-51(106)29-27-47)74(115)100-33-11-24-62(100)72(113)98-58(37-46-14-2-1-3-15-46)69(110)95-55(20-8-30-90-80(84)85)68(109)96-56(21-9-31-91-81(86)87)75(116)101-34-12-25-63(101)77(118)103-44-52(107)40-64(103)71(112)93-42-67(108)94-59(41-53-19-13-35-122-53)70(111)99-60(45-105)76(117)102-43-50-18-5-4-16-48(50)38-66(102)78(119)104-61-23-7-6-17-49(61)39-65(104)73(114)97-57(79(120)121)22-10-32-92-82(88)89/h1-5,13-16,18-19,26-29,35,49,52,54-66,105-107H,6-12,17,20-25,30-34,36-45,83H2,(H,93,112)(H,94,108)(H,95,110)(H,96,109)(H,97,114)(H,98,113)(H,99,111)(H,120,121)(H4,84,85,90)(H4,86,87,91)(H4,88,89,92)/t49?,52?,54-,55+,56-,57-,58-,59?,60-,61?,62-,63-,64?,65?,66+/m0/s1 |
PubChem CID | 122189854 |
ChEMBL | CHEMBL3616878 |
IUPHAR | N/A |
BindingDB | 50121679 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | <10000.0 nM | PMID26316468 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417